- Brazil
- /
- Healthcare Services
- /
- BOVESPA:PARD3
Is Now An Opportune Moment To Examine Instituto Hermes Pardini S.A. (BVMF:PARD3)?
Instituto Hermes Pardini S.A. (BVMF:PARD3), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the past couple of months on the BOVESPA. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, could the stock still be trading at a relatively cheap price? Let’s take a look at Instituto Hermes Pardini’s outlook and value based on the most recent financial data to see if the opportunity still exists.
View our latest analysis for Instituto Hermes Pardini
What is Instituto Hermes Pardini worth?
According to my valuation model, Instituto Hermes Pardini seems to be fairly priced at around 1.38% above my intrinsic value, which means if you buy Instituto Hermes Pardini today, you’d be paying a relatively reasonable price for it. And if you believe that the stock is really worth R$21.70, there’s only an insignificant downside when the price falls to its real value. So, is there another chance to buy low in the future? Given that Instituto Hermes Pardini’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.
Can we expect growth from Instituto Hermes Pardini?
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Instituto Hermes Pardini's earnings over the next few years are expected to increase by 38%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.
What this means for you:
Are you a shareholder? PARD3’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?
Are you a potential investor? If you’ve been keeping an eye on PARD3, now may not be the most optimal time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
So while earnings quality is important, it's equally important to consider the risks facing Instituto Hermes Pardini at this point in time. Every company has risks, and we've spotted 2 warning signs for Instituto Hermes Pardini you should know about.
If you are no longer interested in Instituto Hermes Pardini, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
If you’re looking to trade a wide range of investments, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
About BOVESPA:PARD3
Instituto Hermes Pardini
Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil.
Adequate balance sheet second-rate dividend payer.
Market Insights
Community Narratives

